Cerebral Launches New Opioid Use Disorder Treatment Program to Expand Access Through Telehealth
San Francisco-based telemental health provider Cerebral Inc. recently announced the launch of a new telemedicine for opioid addiction program, aimed at expanding access to...
The Expanding Substance Use Disorder Treatment Industry and the Rise of Virtual Care
Drug overdose deaths in the United States continue to reach alarming new highs, underscoring an urgent public health crisis. In response, the substance use...
Woebot Health Raises $9.5 Million from Leaps by Bayer to Expand AI Mental Health Support
In a major win for digital behavioral health innovation, Woebot Health has secured $9.5 million in new funding from Leaps by Bayer, the investment...
$25.6M Federal Investment Expands Medication-Assisted Treatment for Opioid Use Disorder and Prevents Prescription Drug Misuse
In a pivotal move to tackle America’s overdose epidemic, the U.S. Department of Health and Human Services (HHS) has announced $25.6 million in federal...
White Oak Healthcare Finance Empowers Youth Opportunity Investments with Behavioral Health Growth Capital
White Oak Healthcare Finance has announced a strategic financial partnership with Youth Opportunity Investments (YOI), acting as the sole lender and administrative agent for...
Contingency Management: A Game-Changer in Treating Substance Use Disorders
Substance use disorders (SUDs) continue to present significant challenges across the healthcare landscape. Traditional treatment methods, while helpful for many, have not always succeeded...
